-
"Nature" Potential femoral nasal spray can prevent and treat COVID-19
Time of Update: 2022-04-24
A newly discovered small molecule can be sprayed into people's noses to prevent disease before exposure to COVID-19, according to a study of mice (K18-human ACE2 transgenic mice) led by researchers at Cornell University.
-
Express $140 million to help develop broad-spectrum neutralizing antibody nasal spray to provide protection on the front line of virus invasion
Time of Update: 2022-02-20
Leyden Labs aims to develop an intranasal spray that provides immediate protection from infection and prevents spreading the virus to others .
-
The product PH94B nasal spray introduced by Ai Mai Medical for social anxiety disorder is approved for clinical use
Time of Update: 2022-01-25
PH94B is a potential "first-in-class", fast-acting neurosteroid candidate under development by VistaGen, which has entered a Phase 3 clinical study globally for the treatment of social anxiety disorder (SAD) .
-
New progress has been made in the research on the nasal spray vaccine of the new coronavirus
Time of Update: 2022-01-23
By replacing the G protein of VSV with the S protein of the new coronavirus, Zheng Aihua's research group constructed a replicable rVSV-SARS-CoV-2 vector vaccine and applied for a patent in March 2020 .
-
Tyrvaya nasal spray for the treatment of dry eye is approved by the FDA for marketing
Time of Update: 2021-11-16
On October 18, 2021, Oyster Point Pharma announced that the US FDA has approved Tyrvaya (varenicline) nasal spray for the treatment of dry eye .
-
Luoxin Pharmaceutical's subsidiary introduced Budesolv®, a solution nasal spray of Budesonide
Time of Update: 2021-11-04
successfully completed the European market application. The pivotal phase III clinical trial . > Budesolv® is a water-soluble, preservative-free budesonide nasal spray solution developed using Marinomed's patented technology
-
FDA approves new nasal spray therapy for migraine relief within 15 minutes
Time of Update: 2021-10-11
"Reference materials:[1] Impel NeuroPharma Announces US FDA Approval of Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine.
Retrieved September 3, 2021, from https:// 03/2291459/0/en/Impel-NeuroPharma-Announces-US-FDA-Approval-of-Trudhesa-Dihydroergotamine-Mesylate-Nasal-Spray-for-the-Acute-Treatment-of-Migraine.
-
As a first-line COVID-19 treatment, a simple nasal antibody spray has "great potential"
Time of Update: 2021-09-29
Nanobodies are tightly bound to the SARS-CoV-2 virus, and neutralizing it in cell culture can provide a cheaper and easier-to-use alternative to human antibodies extracted from patients recovered from Covid-19 .
-
Bulletin on September 27, 2021: Domestic nasal spray new crown vaccine is effective within 24 hours
Time of Update: 2021-09-29
As of September 25, 2021, Beijing has reported a total of 40 million doses of new crown virus vaccines, reaching 40,023,400 doses, and a total of 20,387,100 inoculations, of which 19,751,400 have completed the entire vaccination .
-
PHOXBIO announces new coronary pneumonia preventive nasal spray
Time of Update: 2021-09-29
that compared with placebo, pHOXWELL has a significant effect on preventing new coronavirus infections . In two research centers (research center 1, 17. 4% and 54. 6%, p=<0
-
Thailand's nasal spray new crown vaccine is expected to enter clinical trials by the end of the year
Time of Update: 2021-08-26
Agency of Thailand said in a statement on the 10th that the two nasal spray new crown vaccines independently developed by the National Genetic Engineering and Biotechnology Research Center under the agency have now completed the animal experiment stage
-
Bayer's antihistamine nasal spray Astepro receives FDA approval for over-the-counter OTC use
Time of Update: 2021-08-09
In the process of splitting its consumer health business into an independent company, GlaxoSmithKline’s Voltaren Arthritis Pain (diclofenac sodium topical gel) was approved in February last year as an over-the-counter product for adults (18 and 18 years old).
-
Kangzhe Pharmaceutical's Diazepam Nasal Spray Application Accepted
Time of Update: 2021-08-08
Diazepam nasal spray will effectively make up for the market gap and become a long-term and essential treatment for patients with acute recurrent epilepsy .
-
Changchun High-tech nasal spray influenza live attenuated vaccine (liquid dosage form) was approved for clinical trials
Time of Update: 2021-07-21
marketed freeze-dried dosage form product-freeze-dried nasal spray influenza attenuated live vaccine to liquid dosage form . >
-
Announcement of the State Food and Drug Administration on the conversion of prescription budesonide nasal spray to over-the-counter drugs (No. 13 of 2021)
Time of Update: 2021-07-07
doc of the National Medical Products Administration Announcement No.
-
Baike Biologics purchase day: there is no need to use the "nasal spray new crown vaccine", the shingles vaccine is the core growth point
Time of Update: 2021-07-06
Among them, the nasal spray attenuated influenza virus carrier new crown vaccine developed by Xiamen University, Hong Kong University and Beijing Wantai Company has also completed phase one and two clinical trials .
-
What are the opportunities and challenges faced by the nasal spray vaccine in the "front line" of the new crown virus invasion...
Time of Update: 2021-06-23
Although the currently developed injectable new crown vaccine can effectively stimulate the body's antibody and cellular immune response, they cannot effectively stimulate the mucosal immune response .
-
Russia tests children with nasal spray new crown vaccine
Time of Update: 2021-06-21
Official According to TASS news agency, Alexander Günzburg, director of the Institute of Epidemiology and Microbiology, introduced to President Vladimir Putin that the nasal spray vaccine for children is the same as the vaccine currently promoted in Russia.
-
What are the opportunities and challenges facing the nasal spray vaccine in the "front line" of the new crown virus invasion?
Time of Update: 2021-06-21
and typhoid fever are available in oral form . These vaccines taken orally in the form of tablets or solutions can stimulate mucosal reactions in the intestine, and the intestine is one of the main
-
Finland's research and development of nasal spray new crown medicament obtained patent
Time of Update: 2021-05-31
-height: 30px"> Finland's research and development of nasal spray new crown medicament obtained patent
